Saturday, July 11, 2026

pharma · Small Cell Carcinoma of Lung

Shanghai Best-Link Bioscience

Shanghai Best-Link Bioscience clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Intelligence · Clinical Programs

Shanghai Best-Link Bioscience projects

1 ClinicalTrials.gov programs sponsored by Shanghai Best-Link Bioscience.

Shanghai Best-Link Bioscience has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. BL0020

    Shanghai Best-Link Bioscience

    Small Cell Carcinoma of Lung

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Shanghai Best-Link Bioscience have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.